Additionally, we found that there were significant correlations between PBX4 expression and six immune subtypes (i.e., wound healing, IFN-gamma dominant, inflammatory, lymphocyte depleted, immunologically quiet, and TGF-beta dominant) of 10 cancer types, namely BLCA, BRCA, KIRC, KIRP, LGG, LUSC, PRAD, STAD, THCA, and UCEC (Figure 4K–T). Here, PBX4 is linked to cancer.